{"result": "(\"entity\"<|>ESTUDIO ALEATORIZADO<|>EVENT<|>A randomized controlled study involving 78 patients with pancreatic fistulas to compare the effectiveness of enteral versus parenteral nutrition)\n##\n(\"entity\"<|>PACIENTES<|>PERSON<|>Patients involved in the study, specifically those with pancreatic fistulas, who were randomized to receive either enteral or parenteral nutrition)\n##\n(\"entity\"<|>CIERRE DE LA FÍSTULA<|>EVENT<|>The process of closing a pancreatic fistula, which was measured in the study to assess the effectiveness of nutritional interventions)\n##\n(\"relationship\"<|>ESTUDIO ALEATORIZADO<|>FÍSTULA PANCREÁTICA<|>The randomized controlled study focused on patients with pancreatic fistulas to evaluate nutritional support methods<|>8)\n##\n(\"relationship\"<|>PACIENTES<|>FÍSTULA PANCREÁTICA<|>The patients in the study were specifically those suffering from pancreatic fistulas<|>9)\n##\n(\"relationship\"<|>PACIENTES<|>NUTRICIÓN ENTERAL<|>Patients were randomized to receive enteral nutrition as part of the study<|>7)\n##\n(\"relationship\"<|>PACIENTES<|>NUTRICIÓN PARENTERAL<|>Patients were also randomized to receive parenteral nutrition as part of the study<|>7)\n##\n(\"relationship\"<|>CIERRE DE LA FÍSTULA<|>NUTRICIÓN ENTERAL<|>The closure rate of the fistula was higher in patients receiving enteral nutrition<|>8)\n##\n(\"relationship\"<|>CIERRE DE LA FÍSTULA<|>NUTRICIÓN PARENTERAL<|>The closure rate of the fistula was lower in patients receiving parenteral nutrition<|>5)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: estudio aleatorizado prospectivo controlado 78 pacientes con fístula pancreática se aleatorizaron a nutrición enteral o parenteral145. A los 30 días, el cierre de la fístula fue del 60% en el grupo aleatorizado a nutrición enteral frente al 37% en el grupo con nutrición parenteral (p = 0,04). La mediana de tiempo hasta el cierre fue menor en el grupo de enteral. Los dos únicos factores asociados con el cierre de la fístula pancreática fueron la nutrición enteral y un débito inicial de la fístula inferior o igual a 200 cc/día.\n\nEl retraso del vaciamiento gástrico también puede ser tratado mediante nutrición enteral.\n\n## 5. Resumen\n\nLas neoplasias gastrointestinales son la causa más importante de mortalidad por cáncer en todo el mundo.\n\nSe recomienda realizar una evaluación nutricional de estos pacientes lo antes posible con el objetivo de detectar alteraciones nutricionales en un estadio temprano. Se debe hacer en el momento del diagnóstico y periódicamente.\n\nEl tratamiento nutricional de los pacientes con cáncer gastrointestinal es muy importante debido a las relativamente bajas tasas de supervivencia de estos tumores y al peor pronóstico de estos enfermos condicionado por su mal estado nutricional.\n\nUn abordaje nutricional precoz puede ser beneficioso para reducir la morbimortalidad, disminuir la incidencia de complicaciones postoperatorias infecciosas y no infecciosas, aumentar la inmunidad del paciente, disminuir la estancia hospitalaria y el gasto sanitario y para mejorar el pronóstico de ciertos enfermos.\n\nNo existe ninguna enfermedad que mejore con el ayuno. Se recomienda la nutrición enteral si la ingesta oral es inadecuada, a pesar de consejo y suplementos nutricionales, y por vía parenteral cuando la nutrición enteral no es suficiente o posible.\n\nEn pacientes con neoplasias del tracto digestivo superior que precisan cirugía, la inmunonutrición oral / enteral es una opción terapéutica recomendable dados sus beneficios sobre la incidencia de complicaciones infecciosas y no infecciosas, la duración del ingreso y la recuperación del estado nutricional. El uso de este tipo de fórmulas en grupos específicos de enfermos es coste-efectivo para el sistema sanitario.\n\nLa cirugía continúa siendo la principal opción terapéutica curativa en estos pacientes con alto riesgo de desarrollar complicaciones postoperatorias por el estado de malnutrición, la inmunodepresión inducida por el tumor y la respuesta a la agresión quirúrgica. La combinación de quimio y/o radioterapia adyuvante, neoadyuvante y radical seguidas o no de cirugía añaden una enorme complejidad al tratamiento de los pacientes con tumores digestivos y un mayor riesgo de complicaciones. En este contexto, el tratamiento nutricional merece una especial atención dado su impacto sobre la morbilidad y calidad de vida de los pacientes.\n\nLa sarcopenia en el paciente digestivo oncológico es un indicador de menor capacidad física y aumenta el riesgo de infecciones adquiridas y comorbilidades, que pueden condicionar una peor tolerancia y una mayor toxicidad a los tratamientos específicos. En este sentido, se recomienda aumentar la actividad física en estos pacientes para mantener la masa y fuerza musculares, la funcionalidad y el patrón metabólico.\n\nYa que las deficiencias nutricionales pueden presentarse hasta varios años después del diagnóstico y tratamiento de la enfermedad tumoral, es importante seguir a estos enfermos y vigilar su estado nutricional a largo plazo. Esto repercutirá en una mejor calidad de vida en la mayoría de estos supervivientes.\n\n## 6. Bibliografía\n\n1. Song GM, Tian X, Zhang L, Ou YX, Yi LJ, Shuai T, et al. Immunonutrition Support for Patients Undergoing Surgery for Gastrointestinal Malignancy: Preoperative, Postoperative, or Perioperative? A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore). 2015; 94:e1225.\n\n2. Arends J, Bachmann P, Baracos V, Barthelemy N, Bertz H, Bozzetti F, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017; 36:11-48.\n\n3. Bozzetti F, Bozzetti V. Is the intravenous administration of amino acid adequate in cancer patients? A critical appraisal of literature. Clin Nutr. 2013; 32:142e6.\n---\nTema 39. Soporte nutricional en el paciente con cirugía oncológica de estómago, esófago y páncreas 629\n\n4. Rosania R, Chiapponi C, Malfertheiner P, Venerito M. Nutrition in Patients with Gastric Cancer: An Update. Gastrointest Tumors. 2016; 2:178-87.\n\n5. Weimann A, Braga M, Hars\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Nutritional support provided through enteral means for patients with pancreatic fistulas, showing a higher closure rate compared to parenteral nutrition)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Nutritional support provided through parenteral means, which had a lower closure rate for pancreatic fistulas compared to enteral nutrition)\n##\n(\"entity\"<|>FÍSTULA PANCREÁTICA<|>EVENT<|>A medical condition involving an abnormal connection between the pancreas and other organs, which was the focus of the study involving 78 patients)\n##\n(\"entity\"<|>NEOPLASIAS GASTROINTESTINALES<|>EVENT<|>Gastrointestinal neoplasms are a major cause of cancer mortality worldwide, highlighting the importance of nutritional evaluation and support)\n##\n(\"entity\"<|>CÁNCER<|>EVENT<|>A disease characterized by uncontrolled cell growth, with specific focus on gastrointestinal cancers in the context of nutritional support)\n##\n(\"entity\"<|>SARCOOPENIA<|>EVENT<|>A condition characterized by loss of muscle mass and strength, which increases the risk of infections and comorbidities in cancer patients)\n##\n(\"entity\"<|>MALNUTRICIÓN<|>EVENT<|>A state of nutritional deficiency that can complicate treatment and recovery in cancer patients, particularly those with gastrointestinal tumors)\n##\n(\"entity\"<|>QUIMIO Y/O RADIOTERAPIA<|>EVENT<|>Chemotherapy and/or radiotherapy are treatments that add complexity to the management of patients with gastrointestinal tumors)\n##\n(\"relationship\"<|>FÍSTULA PANCREÁTICA<|>NUTRICIÓN ENTERAL<|>Nutritional support through enteral means was shown to be more effective in closing pancreatic fistulas compared to parenteral nutrition<|>8)\n##\n(\"relationship\"<|>FÍSTULA PANCREÁTICA<|>NUTRICIÓN PARENTERAL<|>Nutritional support through parenteral means was less effective in closing pancreatic fistulas compared to enteral nutrition<|>5)\n##\n(\"relationship\"<|>NEOPLASIAS GASTROINTESTINALES<|>CÁNCER<|>Gastrointestinal neoplasms are a significant cause of cancer mortality, emphasizing the need for nutritional support<|>7)\n##\n(\"relationship\"<|>CÁNCER<|>MALNUTRICIÓN<|>Cancer patients often experience malnutrition, which can worsen their prognosis and complicate treatment<|>9)\n##\n(\"relationship\"<|>SARCOOPENIA<|>CÁNCER<|>Sarcopenia is a condition that affects cancer patients, leading to decreased physical capacity and increased risk of complications<|>6)\n##\n(\"relationship\"<|>QUIMIO Y/O RADIOTERAPIA<|>MALNUTRICIÓN<|>Chemotherapy and/or radiotherapy can exacerbate malnutrition in patients, complicating their recovery<|>7)\n##\n(\"relationship\"<|>NEOPLASIAS GASTROINTESTINALES<|>MALNUTRICIÓN<|>Gastrointestinal neoplasms are associated with a high risk of malnutrition, necessitating early nutritional evaluation<|>8)\n<|COMPLETE|>"}]}